Showing results (21-30 of 831) with videos related to

Sort By:
Pageof 84
Blood|October 24, 2002
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Teru Hideshima, Constantine Mitsiades, Masaharu Akiyama, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
Hematology/Oncology Clinics of North America|September 13, 2014
Novel targeted agents in the treatment of multiple myelomaCindy Varga, Jacob Laubach, Teru Hideshima, et al.
Blood|January 19, 2006
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Hiroshi Yasui, et al.
Cancer Research|September 17, 2005
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Blood|April 26, 2003
Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytesToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.
Blood|October 24, 2002
Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieuTeru Hideshima, Masaharu Akiyama, Toshiaki Hayashi, et al.
Cancer Metastasis Reviews|December 3, 2017
The proteasome and proteasome inhibitors in multiple myelomaSara Gandolfi, Jacob P Laubach, Teru Hideshima, et al.
Blood|June 26, 2004
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosisSteven Le Gouill, Klaus Podar, Martine Amiot, et al.
Blood|May 14, 2009
Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cellsTeru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, et al.
Pageof 84